Search
Search titles only
By:
Search titles only
By:
Home
Forums
New posts
Search forums
What's new
New posts
New profile posts
Latest activity
Members
Current visitors
New profile posts
Search profile posts
Log in
Register
Search
Search titles only
By:
Search titles only
By:
New posts
Search forums
Menu
Install the app
Install
Reply to Thread
Guest, we'd love to know what you think about the forum! Take the
Diabetes Forum Survey 2024 »
Home
Forums
Diabetes Discussion
Type 1 Diabetes
Continuous Glucose Monitoring as a Matter of Justice
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Message
<blockquote data-quote="Clarkare" data-source="post: 2264727" data-attributes="member: 312403"><p>Esarkaye. Thank you for an excellent well researched article that whilst being focused on provision in the Netherlands has both currency and relevance to many other health economies. I, as a type 2 diabetic living in the UK do not meet the UK’s National Institutes for Health & Social Care Excellence criteria for state provision of a CGM. Although having a vested interest I would argue that the criteria should focus more on the the treatment regime rather than the often arbitrary classification of the condition. Currently I test 5 times a day and I am on both quick acting and slow release insulin. I do choose to use Libre to assist with my diabetes and as I do not meet the NICE. criteria I self-fund. Like others who use this or similar technology I have dramatically improved my HBA1c stabilising my Diabetes and in doing so help to reduce my use of health services resources. I do accept the argument put forward by NICE that the efficacy of any treatment needs to be weighed against the economic impact on the Health Care budget but ,as in my own case, I believe that there is sufficient evidence that the continued use of a CGM helps to reduce or at least stabilise the financial consequences for the Health Care budget.</p></blockquote><p></p>
[QUOTE="Clarkare, post: 2264727, member: 312403"] Esarkaye. Thank you for an excellent well researched article that whilst being focused on provision in the Netherlands has both currency and relevance to many other health economies. I, as a type 2 diabetic living in the UK do not meet the UK’s National Institutes for Health & Social Care Excellence criteria for state provision of a CGM. Although having a vested interest I would argue that the criteria should focus more on the the treatment regime rather than the often arbitrary classification of the condition. Currently I test 5 times a day and I am on both quick acting and slow release insulin. I do choose to use Libre to assist with my diabetes and as I do not meet the NICE. criteria I self-fund. Like others who use this or similar technology I have dramatically improved my HBA1c stabilising my Diabetes and in doing so help to reduce my use of health services resources. I do accept the argument put forward by NICE that the efficacy of any treatment needs to be weighed against the economic impact on the Health Care budget but ,as in my own case, I believe that there is sufficient evidence that the continued use of a CGM helps to reduce or at least stabilise the financial consequences for the Health Care budget. [/QUOTE]
Verification
Post Reply
Home
Forums
Diabetes Discussion
Type 1 Diabetes
Continuous Glucose Monitoring as a Matter of Justice
Top
Bottom
Find support, ask questions and share your experiences. Ad free.
Join the community »
This site uses cookies. By continuing to use this site, you are agreeing to our use of cookies.
Accept
Learn More.…